- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Imexpharm Corp (IMP)
Imexpharm Corp stock price live, this page displays HM IMP stock exchange data. View the IMP premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Imexpharm Corp real time stock price chart below.
What Is the Imexpharm Corp Stock Price Today?
The Imexpharm Corp stock price today is 37,100.0.
What Is the Stock Symbol for Imexpharm Corp?
The stock symbol for Imexpharm Corp is "IMP."
What Stock Exchange Does Imexpharm Corp Trade On?
Imexpharm Corp is listed and trades on the Ho Chi Minh stock exchange.
Is Imexpharm Corp a Good Stock to Buy?
Determining whether Imexpharm Corp, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the IMP quote. (ISIN: VN000000IMP0)
What Is the Imexpharm Corp Stock Price Today?
The Imexpharm Corp stock price today is 37,100.0.
What Is the Stock Symbol for Imexpharm Corp?
The stock symbol for Imexpharm Corp is "IMP."
What Stock Exchange Does Imexpharm Corp Trade On?
Imexpharm Corp is listed and trades on the Ho Chi Minh stock exchange.
Is Imexpharm Corp a Good Stock to Buy?
Determining whether Imexpharm Corp, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the IMP quote. (ISIN: VN000000IMP0)
37,100.0
-2,000.0(-5.12%)
Real-time Data·
Fair Value
An estimate of a Imexpharm Corp's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
37,100.0
38,800.0
52 wk Range
37,100.0
57,000.0
Trading near 52-week Low
1/2
Fair Value
An estimate of a Imexpharm Corp's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
37,100.038,800.0
52 wk Range
37,100.057,000.0
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.49%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.49%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
IMP Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Imexpharm Corp's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Neutral
Price Target
56,000.0
Upside
+50.94%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high P/E ratio relative to near-term earnings growth
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell
Analyst Ratings
0 Buy
1 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 56,000.0
(+50.94% Upside)
Earnings
Latest Release
Jun 03, 2026
EPS / Forecast
474.46 / --
Revenue / Forecast
546B / --
Compare IMP to Peers and Sector
Metrics to compare | IMP | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipIMPPeersSector | |
|---|---|---|---|---|
P/E Ratio | 19.4x | 19.9x | −0.4x | |
PEG Ratio | 2.25 | 0.59 | 0.00 | |
Price/Book | 2.5x | 3.7x | 2.6x | |
Price / LTM Sales | 2.5x | 2.3x | 3.0x | |
Upside (Analyst Target) | 43.2% | 16.3% | 53.2% | |
Fair Value Upside | Unlock | 18.8% | 9.0% | Unlock |
Imexpharm Corporation operates as a pharmaceutical company in Vietnam. The company’s products include injectable antibiotics, oral antibiotics, cardiovascular, ophthalmology, musculoskeletal system, analgesic - anti-inflammatory - antipyretics, respiratory system, antihistamines and anti-allergy, central nervous system, digestive system, diabetes, anti-parasitic, external drugs, vitamins and minerals, and supplements. It is also involved in the import and export. Imexpharm Corporation was founded in 1997 and is headquartered in Cao Lanh, Vietnam. As of April 29, 2026, Imexpharm Corporation operates as a subsidiary of Livzon Pharmaceutical Group Inc..
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Imexpharm Corp (IMP) Stock Price Today?
The Imexpharm Corp stock price today is 37,100.0 VND.
What Stock Exchange Does Imexpharm Corp Trade On?
Imexpharm Corp is listed and trades on the Ho Chi Minh City Stock Exchange.
What Is the Stock Symbol for Imexpharm Corp?
The stock symbol for Imexpharm Corp is "IMP."
What Is the Imexpharm Corp Market Cap?
As of today, Imexpharm Corp market cap is 5.71T VND.
What Is Imexpharm Corp's Earnings Per Share (TTM)?
The Imexpharm Corp EPS (TTM) is 2,020.2.
When Is the Next Imexpharm Corp Earnings Date?
Imexpharm Corp will release its next earnings report on Sep 02, 2026.
From a Technical Analysis Perspective, Is IMP a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Imexpharm Corp Stock Split?
Imexpharm Corp has split 11 times.
How Many Employees Does Imexpharm Corp Have?
Imexpharm Corp has 1444 employees.
What is the current trading status of Imexpharm Corp (IMP)?
As of Jul 20, 2026, Imexpharm Corp (IMP) is trading at a price of 37,100.0 VND, with a previous close of 39,100.0 VND. The stock has fluctuated within a day range of 37,100.0 VND to 38,800.0 VND, while its 52-week range spans from 37,100.0 VND to 57,000.0 VND.
What Is Imexpharm Corp (IMP) Price Target According to Analysts?
The average 12-month price target for Imexpharm Corp is 56,000.0 VND, with a high estimate of 56000 VND and a low estimate of 56000 VND. 0 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Neutral. The stock has an +50.94% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.